United Maritime Corp (USEA): Financial results for Q2 2026

Seanergy Maritime Holdings (NASDAQ: SHIP) reported Q2 net revenue of $55.7M and net income of $26.2M, up from $37.5M and $2.9M a year earlier, and declared a $0.35/share dividend for its 19th consecutive quarter. It also completed a €100M bond offering and raised its TCE outlook. Spin-off United Maritime (NASDAQ: USEA) reported Q2 revenue of $10M and a $0.10/share dividend.

Eli Lilly (LLY) reports that Foundayo, its oral GLP-1 drug, now accounts for about one-third of new patients starting the treatment. Foundayo generated $98 million in Q2 revenue, contributing to Lilly's total Q2 revenue of $23.0 billion, up 48% YoY. Lilly raised its 2026 revenue guidance to $85 billion-$87 billion and is investing $6.5 billion in a new Houston facility to produce Foundayo and other medicines.

Green Thumb Industries (GTBIF) reported Q2 revenue of $306.7M, EBITDA of $84.3M, and net income of $4.9M. The company grew revenue by 4.6% YoY and maintains a strong balance sheet with $283.6M in cash and $283M in debt. It repurchased 7.9M shares in Q2. Despite challenges, its financial flexibility and potential federal reform make it a notable player in the cannabis industry.

Medtronic (MDT) reported strong Q1 results, raising its fiscal 2027 revenue growth outlook to 7.25-7.75%. The company is investing in high-growth areas like robotic surgery and partnerships, such as a $700M deal for Cornerstone's Sentire Surgical System. However, it faces stiff competition from peers like Johnson & Johnson and Intuitive Surgical. Institutional investors, including BlackRock, are increasing their stakes in MDT.

Samsung Electronics forecasts Q3 revenue of ₩200.279 trillion and operating profit of ₩106.9887 trillion, more than double last year's annual profit. The memory division, particularly DRAM and NAND, is driving this growth, with price increases and high profitability. HBM4 mass production is boosting competitiveness, while non-memory sectors face deficits.

Costco Wholesale (COST) reported annual revenues of $303B and EPS of $20.76, meeting analyst expectations. Shares rose 3.1% to $923. Analysts predict 2027 revenues of $328.3B (8.3% growth) and EPS of $22.78 (9.4% growth), with a consensus price target of $1,058. Growth is expected to outpace industry averages.